Back to search
FDAFDA · Food and drugs·Recall number D-0546-2024

Drug Vial Label: Zilretta® (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01. Carton Label: Drug Vial Label: Zilretta® (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01.

Published June 19, 2024 · Recall initiated: May 7, 2024

Summary

FDA records drug Class II recall D-0546-2024, published June 19, 2024 and initiated May 7, 2024. Recalling firm: PACIRA PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 43,768 kits; Lot: Lot: 082657 (kit 23-9004), Exp: July 2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.

What to do

Voluntary: Firm initiated · Letter

Get an email if ZILRETTA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ZILRETTA
Manufacturer
PACIRA PHARMACEUTICALS INC
Distributor
U.S. Nationwide.
Lot
Lot: 082657 (kit 23-9004), Exp: July 2024.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Drug Vial Label: Zilretta® (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01. Carton Label: Drug Vial Label: Zilretta® (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01. recalled?

Yes. FDA published recall D-0546-2024 on June 19, 2024. Reported hazard: Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ZILRETTA.